Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Undetectable viral load and treatment as prevention news


From To
Navigating rules and reality: HIV disclosure, infectiousness and legal obligations in Sweden

Despite generally positive relationships with HIV clinic staff, men living with HIV in Sweden report that when it comes to rules regarding disclosure and legal obligations, clinicians

06 February 2019
Krishen Samuel
Canada: Groups want provinces to have consistent policies on limiting HIV prosecutions

Advocacy groups are calling on provinces to follow the Justice Department’s directive to stop unjustly prosecuting HIV-positive people for not disclosing their status if there is no chance they could transmit the virus to their sexual partners.

05 February 2019
Vancouver Sun
A Raw, Romantic Campaign Paints a New Narrative of HIV In Vietnam

The message is simple but quite radical: It’s possible for people living with HIV to have a healthy and fulfilling sex life.

29 January 2019
How do we define “undetectable” in HIV prevention?

In real life, whether your viral load is 50, 100, or 200 copies may not matter as much as how long your virus has been suppressed.

23 January 2019
BETA blog
Michigan State updates HIV disclosure laws to reflect impact of effective ART

On 8 January 2019 the outdated HIV disclosure law in the US State of Michigan has been modernised.

23 January 2019
HIV i-Base
Atripla or efavirenz plus Truvada failed one in 16 people in first year

Estimates of how often people on antiretroviral therapy (ART) do not remain virally undetectable are important both in order to gauge the potency of ART, and to

21 January 2019
Gus Cairns
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable

Viewpoint by Dr. Anthony Fauci and colleagues.

11 January 2019
Study Explores Cost-Effectiveness of Conception Strategies for HIV Serodiscordant Couples

A new multi-institutional study has examined the cost-effectiveness of the pre-exposure prophylaxis (PrEP) combination of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) and assisted reproductive options for serodiscordant couples with an HIV-infected male and HIV-uninfected female looking to conceive. The study focused on examining scenarios in which ‘Undetectable=Untransmittable’ (’U=U’) infection, achieved with combination antiretroviral therapy, (cART) is not sufficient for conception.

09 January 2019
Contagion Live
Half of all British men believe people with HIV ‘are out to infect others’

Half of all British men believe people with HIV are 'out to infect others', according to a new study. And it found people are still unaware that hose living with undetectable levels of HIV can not transmit the virus. Mylan, the supplier for the NHS’ PrEP Impact Study, posted the data from its recent survey on HIV awareness.

13 December 2018
Gay Star News
Canada Becomes First Country To Endorse U=U

In recognition of World AIDS day, the Honorable Ginette Petitpas Taylor, Canada’s Minister of Health, officially endorsed the Undetectable = Untransmittable (U=U) campaign.

07 December 2018
HIV Plus Mag
← First12345...74Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.